65219-384-02 : NDC 2026 Code

65219-384-02 : Verapamil Hydrochloride ( Verapamil Hydrochloride )

Additionally :

You can get information about “65219-384-02” NDC code in 65219-384-02 in HTML format

HTML | 65219-384-02 in TXT (Plain Text) format

TXT | 65219-384-02 in PDF (Portable Document Format)

PDF | 65219-384-02 in XML format

XML formats.

NDC Code : 65219-384-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "65219-384-02",
    "PackageDescription": "25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01) ",
    "NDC11Code": "65219-0384-02",
    "ProductNDC": "65219-384",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Verapamil Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Verapamil Hydrochloride",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20241125",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216471",
    "LabelerName": "FRESENIUS KABI USA, LLC",
    "SubstanceName": "VERAPAMIL HYDROCHLORIDE",
    "StrengthNumber": "2.5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-11-26",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20241125",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}